Weert, Netherlands

Roland Lambertus Joannes Lalieu

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Xeltis Ag. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roland Lambertus Joannes Lalieu. Retrieved from https://idiyas.com/inventor/roland-lambertus-joannes-lalieu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Roland Lambertus Joannes Lalieu

Introduction

Roland Lambertus Joannes Lalieu is an accomplished inventor based in CR Weert, Netherlands. He is currently associated with Xeltis AG, a company focused on innovative medical solutions. Despite having no patents to his name, Lalieu's contributions to the field of medical technology are noteworthy.

Latest Patents

As of now, Roland Lalieu holds 1 patents. This indicates that his work may be more focused on research and development rather than patenting inventions.

Career Highlights

Lalieu has made significant strides in his career at Xeltis AG. His role involves working on cutting-edge technologies aimed at improving patient outcomes. His expertise in the medical field has positioned him as a valuable asset to the company.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Roland Lambertus Joannes Lalieu is a dedicated inventor whose work at Xeltis AG reflects his commitment to advancing medical technology. His contributions, although not yet captured in patents, are significant in the realm of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…